Fludrocortisone
Mineralocorticoids
- Drug class
- Mineralocorticoids
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 2
- Products on record
- 21
Overview
Plain-language summary, compiled from the cited regulatory records
Fludrocortisone acetate is a medication classified as a mineralocorticoid [1]. It is used as a partial replacement therapy for individuals with primary and secondary adrenocortical insufficiency, a condition commonly associated with Addison's disease [1]. Additionally, fludrocortisone acetate is indicated for the treatment of salt-losing adrenogenital syndrome [1].
This medication helps the body manage salt and water balance, which is crucial for individuals with conditions affecting the adrenal glands. By supplementing the body's natural hormones, fludrocortisone acetate aims to restore proper physiological function and alleviate symptoms associated with these specific endocrine disorders [1]. Fludrocortisone acetate is available under various brand names.
There were no adverse event reports for fludrocortisone in the past 12 months [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 19 | May 22, 2026 |
| US United States | FDA | 2 | May 19, 2025 |
GBUnited Kingdom· MHRA
19 products
Uses
For partial replacement therapy for primary adrenocortical insufficiency in Addison's disease and for the treatment of salt-losing adrenogenital syndrome.
How to take
USUnited States· FDA
2 products
Uses
INDICATIONS AND USAGE
1 mg are indicated as partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison's disease and for the treatment of salt-losing adrenogenital syndrome.
How to take
Drug interactions
Known interactions involving Fludrocortisone. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 383. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL396990071 · revised January 17, 2025
- [2]FDA DailyMed · 001e72ea-2c9e-46… · revised May 19, 2025 [PDF]
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.